Nodal is a member of the transforming growth factor-b superfamily that plays crucial roles during embryogenesis. Recently, we have reported that Nodal inhibits trophoblast cell proliferation, migration and invasion, but induces apoptosis in the human placenta. In this study, we examined the regulation of Nodal by microRNAs. In silico analysis of Nodal 39UTR revealed a potential binding site for miR378a-5p. In luciferase reporter assays, we found that miR-378a-5p suppressed the luciferase activity of a reporter plasmid containing Nodal 39UTR but this suppressive effect was completely abolished when the predicted target site was mutated. Western blot analysis showed that miR-378a-5p decreased whereas anti-miR-378a-5p increased Nodal protein levels. These results indicate that miR-378a-5p targets Nodal 39UTR to repress its expression. Stable transfection of the miR-378a-5p precursor, mir-378a, into HTR8/SVneo cells enhanced cell survival, proliferation, migration and invasion. Transient transfection of mature miR-378a-5p mimic, and to a lesser extent, siRNA targeting Nodal, produced similar effects. However, anti-miR-378a-5p inhibited cell migration and invasion. In addition, overexpression of Nodal reversed the invasion-promoting effect of miR-378a-5p. Furthermore, miR-378a-5p enhanced, whereas antimiR-378a-5p suppressed, the outgrowth and spreading of extravillous trophoblast cells in first trimester placental explants. Finally, miR378a-5p was detected in human placenta throughout different stages of gestation and in preterm pregnancies, placental miR-378a-5p levels were lower in preeclamptic patients than in healthy controls. Taken together, these findings strongly suggest that miR-378a-5p plays an important role in human placental development by regulating trophoblast cell growth, survival, migration and invasion, and that miR-378a-5p exerts these effects, at least in part, through the suppression of Nodal expression.
Introduction
Placenta is a transient organ that plays pivotal roles during pregnancy (Maltepe et al., 2010) . Placenta develops primarily through the proliferation and differentiation of the trophoblast cells. During early pregnancy, cytotrophoblasts differentiate either into the syncytiotrophoblasts (STB) or the extravillous cytotrophoblasts (EVT). The STB is engaged in the maternalfetal exchange and endocrine function of the placenta. The EVT cells are highly invasive; they invade the endometrium and one third of the myometrium, as well as the associated spiral arteries (Aplin, 2006; Harris, 2010) . Subsequently, the endothelial layer of the maternal spiral arteries are replaced by these invasive EVTs and the arteries are transformed into low resistant vessels which can provide adequate placental perfusion to maintain the growth of fetus (Wang et al., 2009) .
Trophoblast invasion is regulated by hormones and growth factors (Lunghi et al., 2007; Knöfler, 2010) , including members of transforming growth factor (TGF)-b superfamily (Jones et al., 2006) . This multifunctional protein family consists of many growth and differentiation factors, including TGF-bs, bone morphogenetic proteins (BMPs), Activins/Inhibins, growth and differentiation factors (GDFs), as well as Nodal and its related factors (Massagué and Chen, 2000) . Nodal plays critical roles in embryogenesis (Zhou et al., 1993; Nonaka et al., 2002; Chea et al., 2005) . We have previously reported that Nodal and its receptor, activin receptor like kinase 7 (ALK7) are expressed in human placenta (Roberts et al., 2003) . In addition, we have demonstrated that Nodal acts through ALK7 to inhibit trophoblast proliferation and to induce apoptosis (Munir et al., 2004) . More recently, we have found that activation of the Nodal-ALK7 pathway inhibits trophoblast cell migration and invasion (Nadeem et al., 2011) . These findings strongly suggest that Nodal plays important roles in human placental development.
MicroRNAs are naturally occurring small non-coding RNAs that regulate gene expression at the post-transcriptional levels (Ambros, 2004; Bartel, 2004) . They are able to regulate gene expression by targeting the 39 untranslated region (39UTR) of mRNA, resulting in mRNA cleavage and/or translational repression (Pillai, 2005; Zamore and Haley, 2005) . MicroRNAs are involved in the regulation of many developmental and physiological processes and their aberrant expression is linked to human diseases (Thai et al., 2010) . MicroRNAs are found in human placenta (Barad et al., 2004; Luo et al., 2009 ) and abnormal miRNA levels have been reported in placenta obtained from compromised pregnancies, such as preeclampsia (Pineles et al., 2007; Zhu et al., 2009; Enquobahrie et al., 2011; MayorLynn et al., 2011) . However, little is known about the function of miRNAs in human placenta.
To further study the regulation of the Nodal signaling pathway in human trophoblast cells, we searched for miRNAs that may potentially target Nodal and found that miR-378a-5p (formerly known as miR-378 and miR-378*) has a predicted binding site on Nodal 39UTR. It has been reported that miR-378a-5p enhances tumor cell growth (Lee et al., 2007) and may be involved in breast cancer progression (Eichner et al., 2010) . In this study, we examined the effect of miR-378a-5p on trophoblast cells and first trimester placental explants. We demonstrated that miR-378a-5p induced trophoblast cell survival, growth, migration, and invasion and placental explant outgrowth in part by targeting Nodal.
Results

miR-378a-5p represses Nodal expression
To determine whether Nodal can be regulated by miRNAs, we used FindTar (Hua et al., 2006) to predict miRNAs that could potentially target the Nodal 39UTR. A potential binding site for miR-378a-5p was identified at the Nodal 39UTR from nucleotides 183-204 (Fig. 1A) . To test whether miR-378a-5p targets Nodal, we generated reporter constructs containing wildtype or mutated Nodal 39UTR sequences downstream of luciferase coding sequence. Human trophoblast cell line HTR8/ SVneo was co-transfected with a control reporter (without 39UTR), wild-type Nodal 39UTR-luciferase construct, or the construct in which the predicted miR-378a-5p targeting site was mutated, and miR-378a-5p mimic or a negative control (Fig. 1A) . We found that miR-378a-5p significantly decreased luciferase activities in cells transfected with the reporter construct containing wild-type Nodal 39UTR. However, it did not affect the luciferase activity when cells were transfected with constructs containing no Nodal 39UTR or the mutated Nodal 39UTR sequence (Fig. 1A) .
To further determine the regulation of Nodal by miR-378a-5p and the function of miR-378a-5p in trophoblast cells, we generated stable cell lines using a construct expressing the miR-378a-5p precursor, mir-378a (Lee et al., 2007) or its GFP control. Real-time PCR confirmed the increased expression of mature miR-378a-5p in the stable cell line (Fig. 1B) . In addition, western blot analysis showed a clear reduction of Nodal protein level in the stable cells overexpressing mir-378a compared with the control GFP vector-transfected cells (Fig. 1B) . To confirm the effect of miR-378a-5p on Nodal expression and signaling, stable cells expressing mir-378a or control GFP were transfected with anti-miR-378a-5p or its control vector. Western blot analysis showed that anti-miR-378a-5p increased Nodal expression and reversed the effect of mir-378a (Fig. 1C) . To test whether or not the Nodal signaling pathway was affected, we determined total and phosphorylated Smad2 (pSmad2) levels and found that miR-378a reduced, whereas anti-miR-378a-5p increased, not only pSmad2, but also total Smad2 levels (Fig. 1C) .
miR-378a-5p stimulates trophoblast cell proliferation and survival
To study the function of miR-378a-5p in placental development, we first determined its effects on cell proliferation and survival.
The stable cells expressing mir-378a or the GFP control vector were maintained in serum-free or serum-containing media. Under the serum-free conditions, mir-378a expressing cells significantly Fig. 1 . miR-378a-5p targets Nodal. (A) miR-378a-5p targets Nodal 39UTR in luciferase reporter assays. Two constructs, one containing the potential target site of miR-378a-5p at the 39UTR of Nodal (Nodal UTR) and the other having mutations at the seed sequence of miR-378a-5p targeting site (Mut UTR) were used in luciferase assays. HTR8/SVneo cells were transfected with miR-378a-5p or negative control (NC) and a pMIR-luciferase reporter construct without Nodal 39UTR (No UTR), with wild-type Nodal 39UTR (Nodal UTR), or with mutated Nodal 39UTR (Mut UTR). Data are means 6 s.e.m. (n54). Different letters above bars denote statistically significant differences. (B) miR-378a-5p repressed Nodal expression at the protein level. HTR8/SVneo cells stably transfected with mir-378a and a control GFP vector were generated and real-time PCR was used to confirm the overexpression of miR-378a-5p. Western blot, using an anti-Nodal antibody, revealed that Nodal levels were lower in mir-378a stable cells than in the control cells. (C) miR-378a-5p inhibits Smad2 expression and activation. Cells stably transfected with mir-378a or the GFP control vector were transiently transfected with the anti-miR-378a-5p construct or its control GFP vector. Cell lysates were prepared 48 hr after transfection and western blotting was carried out using anti-Nodal, anti-phospho-Smad2 (pSmad2), anti-total Smad2 (Smad2), and anti-b-actin antibodies.
enhanced cell survival compared with the control (Fig. 2A) . When cells were cultured in 2.5, 5, and 10% FBS, the mir-378a-overexpressing cells consistently proliferated faster than the control cells (Fig. 2B ). To confirm this result, cell survival assays were also performed using transient transfection with mir-378a plasmid and miR-378a-5p mimic. Again, overexpression of mir378a resulted in a significant increase in cell survival under serum-free conditions (Fig. 2C) . Transient transfection of miR378a-5p mimic also significantly increased cell numbers as compared with the control. Similarly, knockdown of Nodal using siRNA enhanced cell survival (Fig. 2D) .
miR-378a-5p promotes trophoblast cell migration and invasion
We have previously shown that Nodal acts through ALK7 to inhibit cell migration and invasion in trophoblast cells (Nadeem et al., 2011) . To study if the regulation of miR-378a-5p on Nodal signaling pathway would affect these biological processes, we tested the effect of miR-378a-5p on trophoblast cell migration and invasion. Wound healing assays were first performed to determine the function of miR-378a-5p in trophoblast cell migration. A wound was made when cells were grown to confluence. The ability of cells to migrate into the wound area was monitored and quantified. The mir-378a stable cells migrated significantly faster than the control cells, reaching a complete wound closure at 48 hr (Fig. 3A) . Similar results were observed in miR-378a-5p-mimic-transfected cells, and this accelerated effect on migration was partially mimicked by siRNA-mediated Nodal silencing (Fig. 3B) . The effect of miR-378a-5p on trophoblast cell migration was further investigated using a transwell migration assay. Since miR-378a-5p enhanced cell proliferation, to eliminate the potential cofounding effect of cell proliferation on cell migration, the migration experiments were conducted in the presence of mitomycin C to arrest cell proliferation. Indeed, when cells were pretreated with mitomycin C for 2 hr, there was no increase in cell number either in the control-or miR-378a-5p-transfected cells over a 24 hr culture period (Fig. 3C ). When cells were transfected with miR-378a-5p mimic or Nodal siRNA, the number of cells migrated through the transwell insert increased significantly (Fig. 3D ). On the other hand, anti-miR-378a-5p suppressed cell migration (Fig. 3E) .
Several experiments were carried out to examine the effect of miR-378a-5P on cell invasion using transwell invasion assays. First, control or miR-378a-5p-transfected cells were treated with or without mitomycin C and cell invasion through Matrigelcoated transwell inserts was determined. As shown in Fig. 4A , although mitomycin C decreased the number of cell invaded through the Matrigel, miR-378a-5p increased cell invasion both in the presence and the absence of mitomycin C. Subsequent experiments were conducted without mitomycin C treatment. In cells stably transfected with mir-378a (Fig. 4B ) or transiently transfected with miR-378a-5p mimic (Fig. 4C ), the number of invaded cells increased significantly. Similarly, transfection with Nodal siRNA had a stimulatory effect on cell invasion (Fig. 4C) . Finally, when cells were transfected with anti-miR-378a-5p, there was a significant decrease in cell invasion, as compared with the control plasmid-transfected cells (Fig. 4D) .
To confirm that miR-378a-5p exerted its invasion-promoting effect by targeting Nodal, two Nodal expression plasmids, one containing the full-length Nodal without 39UTR and the other encoding the mature domain of Nodal with the 39UTR, were used in rescue experiments. In cells transfected with the expression plasmid containing Nodal precursor coding sequence without the 39UTR, overexpression of Nodal was detected and the Nodal expression level was decreased by Nodal siRNA but unaffected by miR-378a-5p (Fig. 5A ). Nodal overexpression reversed the stimulatory effect of miR-378a-5p on cell invasion (Fig. 5B ). In contrast, when cells were transfected with the Nodal plasmid containing both the coding and 39UTR sequences, Nodal overexpression was inhibited by both Nodal siRNA and miR378a-5p (Fig. 6A) , and the effect of miR-378a-5p on cell invasion was not blocked by transfection of this Nodal plasmid (Fig. 6B ).
miR-378a-5p enhances placental explants outgrowth Placenta explants were used as a model to further assess the physiological role of miR-378a-5p in EVT invasion and migration. Explants from placenta obtained from 6-9 weeks of pregnancy were treated with miR-378a-5p mimic or anti-miR-378a-5p for 2 days and the outgrowth of explants was monitored. As shown in (Fig. 7A) , miR-378a-5p significantly enhanced the outgrowth of EVT from the explants. In contrast, anti-miR-378a-5p significantly inhibited the EVT outgrowth in placental explants (Fig. 7B) .
miR-378a-5p is expressed in placenta and dysregulated in preeclampsia
To further assess the physiological significance of miR-378a-5p during human placental development, we determined miR-378a-5p levels in placenta obtained at different stages of pregnancy. We also compared placental miR-378a-5p levels between preeclamptic patients and their gestational age-matched control subjects. During different stages of gestation, miR-378a-5p levels were higher in first and second trimester than in third trimester placenta (Fig. 8A) . In preterm delivery cases, there was a significantly lower level of miR-378a-5p in placentae obtained from preeclamptic patients than in placentae from healthy subjects (Fig. 8B) . However, in term placentae, there was no difference in the miR-378a-5p level between control subjects and preeclamptic patients (Fig. 8C) .
Discussion
MicroRNAs are emerging as major players in gene regulation and contribute to diverse biological processes. Recently, key proteins involved in miRNA biosynthesis have been detected in placenta and miRNA expression profiles have been explored in placenta from healthy and compromised pregnancies (Donker et al., 2007; Luo et al., 2009; Enquobahrie et al., 2011; MayorLynn et al., 2011) , suggesting the potential role of miRNAs in regulating placental development and function. However, how miRNAs regulate trophoblast cell function and placental development is largely unknown. In this study, we provide evidence that miR-378a-5p can promote trophoblast cell survival, proliferation, migration and invasion by targeting Nodal. We also demonstrate that miR-378a-5p levels in the placenta vary with gestational stages and are dysregulated in pregnancies compromised by preeclampsia.
To study miR-378a-5p functions in human placenta, we first used stable and transient transfection of its precursor, mir-378a, as well as transient transfection of miR-378a-5p mimic or its inhibitor in a trophoblast cell line. We found that miR-378a-5p has potent stimulatory effects on trophoblast cell survival, proliferation, migration and invasion. On the other hand, inhibition of endogenous miR-378a-5p by anti-miR-378a-5p miR-378a-5p promotes trophoblast cell invasion 3127 resulted in an inhibition of cell migration and invasion, suggesting that the endogenous miR-378a-5p plays an important role in regulating these cell activities. To further confirm these results, we used a first trimester placental explants culture system to test the effect of miR-378a-5p. The placental explant culture is an excellent model for studying placenta physiology and pathology as it not only preserves actual organization of the villous structure but also very closely mimic the in vivo physiological microenvironment (Caniggia et al., 1999 , Baczyk et al., 2009 Nadeem et al., 2011) . In explant cultures, miR-378a-5p significantly enhanced the outgrowth and spreading of EVT while the miR-378a-5p inhibitor had the opposite effects. Finally, we detected the expression of miR378a-5p in placenta throughout different stages of gestation. Interestingly, placental miR-378a-5p levels are higher during the first and second trimerster of pregnancy than in the third trimester. These findings strongly suggest that miR-378a-5p plays important physiological roles in placental development. By promoting trophoblast cell proliferation and survival, miR-378a may contribute to the rapid growth of placenta during early to mid-pregnancy and by enhancing migration and invasion, miR378a may play a role in regulating trophoblast invasion into the deciduas and myometrium.
Nodal is a member of the TGF-b superfamily known to play critical roles during early embryonic development (Weng and Stemple, 2003) . It also regulates trophoblast differentiation and placental development in mouse (Ma et al., 2001) . In human placenta, we have demonstrated that Nodal inhibits trophoblast proliferation, migration, and invasion while inducing their apoptosis (Munir et al., 2004; Nadeem et al., 2011) . The present study demonstrates that Nodal is a target of miR-378a-5p and that the effects of miR-378a-5p on trophoblast cells are partially mediated by Nodal. Using in silico analysis, mutagenesis, luciferase reporter assays, and western blot analyses, we showed that miR-378a-5p interacts with a partially complementary sequence on the Nodal 39UTR to inhibit its expression. In functional assays, we found that knockdown of Nodal using siRNA produced similar effects as miR-378a-5p on trophoblast cell survival, migration and invasion. On the other hand, overexpression of Nodal reversed the effect of miR-378a-5p. Consistent with our previous observation that Nodal inhibits, while Nodal siRNA stimulates the outgrowth of first trimester placental explants, miR-378a-5p and miR-378a-5p inhibitor enhances and represses placental explants outgrowth, respectively. Thus, it is very possible that miR-378a-5p exerts regulatory effects on trophoblast cells by targeting the Nodal signaling cascade. Abnormal placentation, such as shallow invasion of trophoblast cells into deciduas and subsequent defects in spiral artery remodeling, has been implicated in the pathogenesis of preeclampsia (Chelbi and Vaiman, 2008) . The TGF-b superfamily has been suggested to play a role in the development of this disorder (Caniggia et al., 1999; Muttukrishna et al., 2000; Venkatesha et al., 2006; Wang et al., 2009 ). Recent studies have also suggested that miRNAs are involved in the pathogenesis of preeclampsia (Zhang et al., 2010; Enquobahrie et al., 2011; Gunel et al., 2011) . We found that in preterm pregnancies, miR-378a-5p levels were lower in placentae obtained from preeclamptic patients compared to healthy controls. It is possible that a reduced miR378a-5p expression would lead to reduced trophoblast cell migration and invasion, this in turn, could lead to insufficient transformation of the maternal spiral arteries, thereby contributing to preeclampsia. A decrease in miR-378a-5p may also lead to excessive apoptosis of trophoblast cells, a condition commonly observed in preeclampsia (DiFederico et al., 1999; Whitley et al., 2007) . It remains to be determined what factors regulate miR-378a-5p expression in healthy and pathological placentae.
It is well accepted that a miRNA can target many genes. In all experiments we have performed, we consistently noticed a stronger effect of miR-378a-5p than siRNA targeting Nodal. It is possible that additional genes are involved in miR-378a-5p-regulated trophoblast cell activities. Database mining revealed that Smad2 and plaminogen activator inhibitor (PAI-1) are potential target genes of miR-378a-5p. In our western blot analysis using cell lysates prepared from GFP and mir-378a stable cell lines transfected with or without anti-miR-378a-5p, we 
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found that total Smad2 levels were decreased by mir-378a but increased by anti-miR-378a-5p. This result suggests that miR378a-5p may also regulate Smad2 expression. Since Smad2 is an intracellular mediator of Nodal signaling pathway (Schier, 2003; Jia et al., 2008) , downregulation of Smad2 is expected to have Fig. 7 . MiR-378a-5p stimulates placental explant outgrowth. (A) First trimester placental explants were treated with miR-378a-5p or negative control (NC) oligonucleotide. Representative images of the tissues before treatment and 48 hr after treatment and a summary graph showing the outgrowth area are shown. The area of outgrowth was calculated by subtracting the total outgrowth area at the end of the experiment from that of the initial area before treatment. Data were converted to fold negative control (NC) before combining the results of the four experiments. Data are means 6 s.e.m. (n54). *P,0.05 vs NC. (B) Anti-miR-378a-5p inhibits placental explant outgrowth. First trimester placental explants were treated with antimiR-378a-5p or its control oligonucleotide for 48 hr and analyzed as described in A. *P,0.05 vs control (n54). Fig. 8 . Expression of miR-378a-5p in human placenta. (A) miR-378a-5p levels in first (5-12 weeks, n513), second (13-25 weeks, n512) and third (26-40 weeks, n543) trimester placentae. Different letters denote statistically significant differences. (B) miR-378a-5p levels in preterm delivery placentae (26-33 weeks) compromised by preeclampsia (n515) or their gestational agematched control subjects (n522). *P,0.05 vs control. (C) miR-378a-5p levels in term delivery placentae (34-40 weeks) compromised by preeclampsia (n511) or their gestational age-matched control subjects (n521). Data are means 6 s.e.m. similar effects as the inhibition of Nodal expression. PAI-1 has been shown to inhibit trophoblast cell invasion and it is a known target gene of TGF-b in trophoblast (Graham, 1997; Chakraborty et al., 2002; Ma et al., 2002) . It may also be a mediator of Nodal action in placenta but this needs to be confirmed in future studies. Furthermore, miR-378a-5p has been shown to promote cell survival and tumor growth by targeting two tumor suppressor genes, Fus-1 and SuFu (Lee et al., 2007) . It has also been reported that miR-378a-5p regulates progression of human breast cancer by targeting estrogen-related receptor-c (ERRc) and GAbinding protein a (GABPA), which are involved in oxidative energy metabolism (Eichner et al., 2010) . Whether or not these identified target genes of miR-378a-5p are involved in human placental development remain to be determined.
Materials and Methods
Cell lines and cell culture
The immortalized first trimester trophoblast cell line HTR8/SVneo was obtained from Charles Graham (Queen's University, Kingston, Canada) and cultured as previously reported (Graham et al., 1993) . Briefly, cells were cultured in RPMI 1640 medium (Invitrogen, Burlington, ON) supplemented with 100 units/ml penicillin, and 100 mg/ml streptomycin (Invitrogen, Burlington, ON) in the presence of 10% fetal bovine serum (Sigma-Aldrich Canada Ltd, Oakville, ON).
Plasmids and transfection
The mir-378a plasmid that expresses the miR-378a-5p precursor and its control GFP vector have been reported previously (Lee et al., 2007) . The anti-miR-378a-5p construct was generated using a similar approach (Lee et al., 2007 ). An expression plasmid containing full-length Nodal without 39UTR in pcDNA4 has been reported (Munir et al., 2004) . A plasmid containing cDNA encoding mature Nodal domain and 39UTR in pCS2 was kindly provided by Karanu Sampath (National University of Singapore, Singapore) (Tian et al., 2008) . To generate cells stably transfected with mir-378a, HTR8/SVneo cells were transfected with the mir-378a or its control GFP vector. Transfected cells were collected using flow cytometry and GFP-positive cells were pooled for experiments. Transient transfection of plasmids, miRNA mimic or siRNA duplexes were carried out using Lipofectamine 2000 (Invitrogen, Burlington, ON) following the manufacturer's suggested procedure, as previously reported Ye et al., 2011) . Nodal siRNA (Nadeem et al., 2011) , miR-378a-5p mimic and non-targeting negative control, were purchased from GenePharma Co.
(Shanghai, China).
RNA extraction and real-time PCR
Total RNA was extracted from cells or tissues using TRIzol reagent (Invitrogen, Burlington, ON) following the manufacturer's instructions with slight modification to enrich small RNA, as previously described (Ye et al., 2011) . Reverse transcription was performed using QuantiMir RT Kit (System Biosciences, CA, USA) and real-time PCR was conducted using SYBR Green and Chromo4 TM Real time detection system (Bio-Rad, Mississauga, ON) (Ye et al., 2011) . U6 was used as an internal control to normalize miR-378a-5p levels.
Generation of Nodal 39UTR reporter constructs and luciferase activity assays
A cDNA fragment representing nucleotide 1-621 of the human Nodal mRNA 39UTR which contains the predicted miR-378a-5p target site (183-204) was obtained by RT-PCR and cloned into pMIR-Report (Ambion, Austin, TX) downstream of the luciferase coding sequence. A mutant construct which contains five nucleotide mutations at the predicted miR-378a-5p binding seed region (200) (201) (202) (203) (204) was created by PCR mutagenesis method. HTR8/SVneo cells were seeded in 12-well plates at the density of 1610 5 cells/well and co-transfected with control or miR-378a-5p mimic, 0.2 mg pMIR-Report-Nodal 39UTR plasmids, and 0.04 mg pRL-TK internal control (Promega, Madison, WI) plasmids. Twenty-four hours after transfection, luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturers' instructions.
Production of rabbit anti-human Nodal polyclonal antibody
Polyclonal antiserum against a peptide (NGRVLLDHHKDMIVEEC) corresponding to amino acid 306-322 of the human Nodal C-terminal region was synthesized by Alpha Diagnostic Intl., Inc. (San Antonio, TX) and four New Zealand white rabbits were inoculated for antibody production. The primary injection was antigen mixed with complete Freund adjuvant. The same amount of antigen mixed with incomplete Freund adjuvant was injected for boosts. Following the second boost, the antiserum activities were examined by ELISA. After primary immunization and 4 additional injections, the antisera from all of the rabbits were screened, and the best titrated one was used for western blot detection of Nodal.
Protein extraction and western blot analysis
Cell lysates were prepared using radioimmune precipitation assay buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, and 1% SDS). Protein samples were subjected to SDS-polyacrylamide gel electrophoresis and transferred onto a PVDF membrane. The membrane was blocked with TBST (10 mM Tris-Cl pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 5% nonfat dry milk powder at room temperature for 1 hr. The membrane was then incubated with the rabbit anti-Nodal polyclonal antibody (1:1500) at 4˚C overnight. After washing with TBST, the membrane was incubated with HRP-anti-rabbit secondary antibody at room temperature for 1 hr. Signals were detected using an ECL Kit (Amersham Biosciences) according to the manufacturer's protocol.
Cell survival and proliferation assay
For survival assays, cells were cultured in serum-free RPMI 1640 medium for 5-7 days. To determine cell growth and proliferation, cells were cultured in medium containing 2.5, 5 or 10% FBS in 6-well culture plates for 48 hr and cell number was counted using the trypan blue exclusion method.
Wound healing assay
Cells were cultured in six-well plates until confluence. A wound was made using a 200 ml pipette tip and 10 points along the wound were marked randomly. The distance between two sides of the wound was measured immediately (0 hr) and again at 24 and 48 hr after wounding using the SimplePCI software program (Compix Inc.,Township, PA). Distances migrated by the cells were calculated by subtracting the width of the wound at 24 or 48 hr from that of the 0 hr time point.
Transwell invasion and migration assay
Cell invasion was determined using a polycarbonate membrane cell culture insert (Costar, Corning incorporated, NY) coated with growth factor reduced Matrigel (BD Biosciences, Bedford, MA) as previously described (Nadeem et al., 2011) . Stable cells expressing GFP control or mir-378a were placed on top of the wells at the density of 2610 5 cells/well. In some experiments, HTR8/SVneo cells were transiently transfected with miR-378a-5p mimic, Nodal siRNA, or negative control. For mitomycin C (Sigma-Aldrich Canada) treatment, cells were incubated with mitocycin C (10 mg/ml) for 2 hr before being placed on the top of the transwell inserts. To determine if the effect of miR-378a-5p on cell invasion is due to inhibition of Nodal expression, 'rescue' experiments were performed using Nodal expressing plasmids with or without the 39UTR sequence. Cells were first transfected with miR-378a-5p mimic or control and 24 hr later, transfected with Nodal or its control plasmids. To examine the role of endogenous miR-378a-5p, cells were transfected with 4 mg/well of control GFP or anti-miR-378a-5p plasmid. In all experiments, transfected cells were collected using Accutase (Innovative Cell Technologies Inc. San Diego, CA), resuspended in RPMI-1640 medium containing 1% FBS and seeded onto the top of the Matrigel-coated culture inserts. Cells were allowed to invade through the pores on the culture insert for 24 hr. Non-invaded cells on the upper surface of the membrane were removed with a cotton swab, and the invaded cells on the lower surface of the membrane were fixed and stained with a Harleco hemacolor stain kit (EMD, NJ, USA). Invaded cells were counted under a microscope. Transwell cell migration assays were performed by using the same methods as the invasion assays except that the transwell insert was not coated with Matrigel.
Human placental tissue collection and explant culture
Fresh and frozen placental tissues from 102 women were used in this study. The samples were obtained through the Biobank program at the Research Centre for Women's and Infants' Health, the Mount Sinai Hospital. The tissues were collected from informed and consented patients at the Department of Obstetrics and Gynaecology, Mount Sinai Hospital, and at the Morgantaler Clinic. The collection and use of placental samples was approved by the Mount Sinai Hospital Research Ethics Board. Sixty-eight samples from first trimester (5-12 weeks, n513), second trimester (13-25 weeks, n512) and third trimester (26-40 weeks, n543) were used to compare miR-378a-5p expression profiles during different stages of gestation. The 43 third trimester placental samples were also used as the preterm (26-33 weeks, n522) and term (34-40 weeks, n521) controls for placental samples obtained from preeclamptic patients (n515 for preterm and n511 for term). Clinical data for the preeclamptic patients and the preterm and term controls are summarized in Table 1 . Eight fresh first-trimester placentae (6-9 weeks), obtained from patients undergoing terminated pregnancies through dilatation and curettage procedure, were used in the placental explants culture. Explant cultures were performed as previously reported (Nadeem et al., 2011) . Briefly, small placental villi were dissected and placed on transwell inserts (Millipore, Corporation, USA) pre-coated with Matrigel. Explants were allowed to attach to the Matrigel overnight and then supplied with serum-free culture medium containing 200 nM of control or miR-378a-5p mimic. In a separate experiment, explants were treated with anti-miR-378a-5p or its negative control (both were purchased from Ambion). Explants were photographed before and 48 hr after treatment, and EVT outgrowths were measured by ImageJ software. Areas of outgrowth were determined by subtracting the total outgrowth area at 48 hr from that at 0 hr. Each treatment was conducted in triplicate and each experiment was carried out four times using different placentae.
Statistic analysis
Results are expressed as the mean 6 s.e.m. One-way analysis of variance was used to determine the differences among several groups, followed by StudentNewman-Keul's test using GraphPad InStat software. Student's t-test was used for two group comparisons. Statistical significance was defined as P,0.05.
